|
1
|
Nathan H, Segev DL, Mayo SC, Choti MA,
Cameron AM, Wolfgang CL, Hirose K, Edil BH, Schulick RD and Pawlik
TM: National trends in surgical procedures for hepatocellular
carcinoma: 1998–2008. Cancer. 118:1838–1844. 2012.
|
|
2
|
Carmena M and Earnshaw WC: The cellular
geography of aurora kinases. Nat Rev Mol Cell Biol. 4:842–854.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang XH, Rao M, Loprieato JA, et al:
Aurora A, Aurora B and survivin are novel targets of
transcriptional regulation by histone deacetylase inhibitors in
non-small cell lung cancer. Cancer Biol Ther. 7:1388–1397. 2008.
View Article : Google Scholar
|
|
4
|
Lam AK, Ong K and Ho YH: Aurora kinase
expression in colorectal adenocarcinoma: correlations with
clinicopathological features, p16 expression, and telomerase
activity. Hum Pathol. 39:599–604. 2008. View Article : Google Scholar
|
|
5
|
Lee EC, Frolov A, Li R, Ayala G and
Greenberg NM: Targeting Aurora kinases for the treatment of
prostate cancer. Cancer Res. 66:4996–5002. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Terakawa T, Miyake H, Kumano M and
Fujisawa M: Growth inhibition and enhanced chemosensitivity induced
by down-regulation of Aurora-A in human renal cell carcinoma Caki-2
cells using short hairpin RNA. Oncol Lett. 2:713–717. 2011.
|
|
7
|
Tanaka S, Arii S, Yasen M, Mogushi K, Su
NT, Zhao C, Imoto I, Eishi Y, Inazawa J, Miki Y and Tanaka H:
Aurora kinase B is a predictive factor for the aggressive
recurrence of hepatocellular carcinoma after curative hepatectomy.
Br J Surg. 95:611–619. 2008. View
Article : Google Scholar
|
|
8
|
Kuang Y, Cai J, Li D, Han Q, Cao J and
Wang Z: Repression of Dicer is associated with invasive phenotype
and chemoresistance in ovarian cancer. Oncol Lett. 5:1149–1154.
2013.PubMed/NCBI
|
|
9
|
Park HS, Park WS, Bondaruk J, et al:
Quantitation of Aurora kinase A gene copy number in urine sediments
and bladder cancer detection. J Natl Cancer Inst. 100:1401–1411.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang XX, Liu R, Jin SQ, Fan FY and Zhan
QM: Overexpression of Aurora-A kinase promotes tumor cell
proliferation and inhibits apoptosis in esophageal squamous cell
carcinoma cell line. Cell Res. 16:356–366. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qi W, Cooke LS, Liu X, Rimsza L, Roe DJ,
Manziolli A, Persky DO, Miller TP and Mahadevan D: Aurora inhibitor
MLN8237 in combination with docetaxel enhances apoptosis and
anti-tumor activity in mantle cell lymphoma. Biochem Pharmacol.
81:881–890. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shimomura T, Hasako S, Nakatsuru Y, et al:
MK-5108, a highly selective Aurora-A kinase inhibitor, shows
antitumor activity alone and in combination with docetaxel. Mol
Cancer Ther. 9:157–166. 2010. View Article : Google Scholar
|
|
13
|
Harrington EA, Bebbington D, Moore J, et
al: VX-680, a potent and selective small-molecule inhibitor of the
Aurora kinases, suppresses tumor growth in vivo. Nat Med.
10:262–267. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fiskus W, Wang Y, Joshi R, et al:
Cotreatment with vorinostat enhances activity of MK-0457 (VX-680)
against acute and chronic myelogenous leukemia cells. Clin Cancer
Res. 14:6106–6115. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin ZJ: Addition in drug combination.
Zhongguo Yao Li Xue Bao. 1:70–76. 1980.(In Chinese).
|
|
16
|
Jeng YM, Peng SY, Lin CY and Hsu HC:
Overexpression and amplification of Aurora-A in hepatocellular
carcinoma. Clin Cancer Res. 10:2065–2071. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin ZZ, Jeng YM, Hu FC, Pan HW, Tsao HW,
Lai PL, Lee PH, Cheng AL and Hsu HC: Significance of Aurora B
overexpression in hepatocellular carcinoma. Aurora B Overexpression
in HCC. BMC Cancer. 10:4612010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin ZZ, Hsu HC, Hsu CH, et al: The Aurora
kinase inhibitor VE-465 has anticancer effects in pre-clinical
studies of human hepatocellular carcinoma. J Hepatol. 50:518–527.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu Y, Zhang Y, Hu J, et al: MARVELD1
inhibited cell proliferation and enhance chemosensitivity via
increasing expression of p53 and p16 in hepatocellular carcinoma.
Cancer Sci. 103:716–722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Katayama H, Sasai K, Kawai H, Yuan ZM,
Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA and Sen
S: Phosphorylation by aurora kinase A induces Mdm2-mediated
destabilization and inhibition of p53. Nat Genet. 36:55–62. 2004.
View Article : Google Scholar : PubMed/NCBI
|
